Aiming at detecting EAAT2 protein on plasma EV surface in a larger MS patient cohort, a flow cytometry-based approach, suitable to detect low abundant EV subsets, like CNS-derived EVs, in a complex body fluid such as plasma, was established. The gene discussed is SLC1A2; the disease is myeloid sarcoma.